Crescent Biopharma, Inc.
$17.75
-0.01 (-0.06%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +18.2%
- 3 Months
- -14.0%
- YTD
- +49.7%
- 1 Year
- +24.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 78.5%
- Largest decline max drawdown, since Aug 2025
- -46.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.67
Own CBIO?
See how CBIO contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.